TacticScaleWhat Tenet Healthcare Does & How It Makes Money (THC)
Updated October 2026 · reflects Tenet Healthcare's latest reported financials
US hospital and outpatient surgery center operator. Tenet earns revenue by charging patients and their insurers for inpatient, outpatient, emergency and surgical services at its hospitals, surgery centers and other care facilities.
How Tenet Healthcare makes money
Tenet earns revenue by charging patients and their insurers for inpatient, outpatient, emergency and surgical services at its hospitals, surgery centers and other care facilities.
What Tenet Healthcare does
Tenet Healthcare is a Dallas-based US healthcare services company, founded in 1967, that operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general and specialty hospitals provide a full range of acute care, including operating rooms, intensive and coronary care, radiology, labs and pharmacies. They also offer advanced tertiary services such as cardiothoracic surgery, complex spine surgery, neonatal intensive care, level 1 trauma, stroke care and pediatric heart, liver and kidney transplants. Beyond hospitals, Tenet runs a large outpatient network of ambulatory surgery centers, surgical hospitals, off-campus emergency departments, imaging centers, urgent care centers and micro-hospitals. The ambulatory business focuses on procedures such as orthopedics and total joint replacement, spine, gastroenterology, pain management, ENT, ophthalmology and urology, which are increasingly done outside traditional hospitals.
Products & services
- Acute care and specialty hospitals
- Ambulatory surgery centers and surgical hospitals
- Emergency, trauma and critical care services
- Tertiary and pediatric transplant programs
- Orthopedic and total joint replacement procedures
- Imaging centers, urgent care and micro-hospitals
What is Tenet Healthcare worth?
On an owner-earnings DCF, Tenet Healthcare's most-likely value is about $742 versus a recent price near $264 (181% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$360) with a margin of safety — so the honest verdict here is “Deeply discounted.” Fair value earns its keep only at the extremes, not in the wide middle.
On the financials alone, $264 is below even the no-growth floor ($360); the market's discount — expectations and sentiment beyond the numbers — is pricing in ≈ -3.3%/yr. A bargain only if that pessimism is overdone.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
HCA Healthcare (HCA) · Healthcare Realty Trust (HR) · Centene (CNC) · U.S. Physical Therapy (USPH) · CareTrust REIT (CTRE)